LON/0HF3 (LON/0HF3)

London Stock Exchange: LON/0HF3 · USD

$326

-1.57 (-0.5%)· Recorded snapshot

Market cap	46.7B
Revenue (ttm)	250.8B
Net income (ttm)	2B
EPS (ttm)	$10.1
P/E (trailing)	24.2x
P/E (forward)	16.9x
Dividend	$1.81 (0.74%)
Volume	1,534
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 250.8B
Net income (ttm): 2B
EPS (ttm): $10.1
P/E (trailing): 24.2x
P/E (forward): 16.9x
Market cap: 46.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E16.9

P25 n/aP50 n/aP75 n/a

Trailing P/E24.2

P25 n/aP50 n/aP75 n/a

ROE96.9

P25 n/aP50 n/aP75 n/a

ROIC20.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All LON/0HF3 indicators

Market & fundamental data

Available fields

247

Groups with data

Currency

USD

Showing 247 of 247 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United States
Country code	UK
Earnings date	2026-11-04
Employees	49,000
Employees change	5,000
Employees growth	10.87%
Enterprise value	$55.6B
Exchange	London Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	September
Founded	1871
Industry	Medical Distribution
Is primary listing	No
ISIN number	US03073E1055
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Market cap	$46.7B
Next earnings date	2026-11-04
Price	$325.73
Price currency	USD
Sector	Healthcare
SIC code	5122
Stock price date	2026-10-28
Symbol	lon/0HF3
Website	https://www.cencora.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	22.13x
Average P/E ratio (3Y)	28.29x
Average P/E ratio (5Y)	24.33x
Earnings yield	4.13%
EV/Earnings	28.08x
EV/EBIT	16.46x
EV/EBITDA	12.45x
EV/FCF	18.15x
EV/Sales	0.22x
FCF / EV yield	5.51%
FCF yield	6.56%
Forward P/E	16.87x
Graham number	72.77289
Graham upside	-77.66%
Lynch fair value	$218.48
Lynch upside	-32.93%
P/(FCF - SBC) ratio	15.83x
P/(OCF - SBC) ratio	13.25x
P/B ratio	19.11x
P/E ratio	24.2x
P/FCF ratio	15.25x
P/OCF ratio	12.84x
P/S ratio	0.19x
Price/EBITDA ratio	11.16x
Sector forward P/E	14.49x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.35%
EBITDA margin	1.67%
Effective tax rate	26.82%
FCF margin	1.22%
Gross margin	3.96%
Operating margin	1.35%
Pretax margin	1.08%
Profit margin	0.79%
Profit per employee	$40,374
Profitable quarters	3
Profitable years	5
Revenue per employee	$5.1M
ROA	3.56%
ROA (5Y)	2.99%
ROCE	18.25%
ROE	96.87%
ROIC	20.95%
ROIC (5Y)	47.06%
SBC / revenue	0.04%
Tax / revenue	0.29%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	39.11%
EPS growth (Q)	11.93%
EPS growth (QoQ)	-53.1%
EPS growth 10Y	6.18%
EPS growth 3Y	18.02%
EPS growth quarters	3
EPS growth years	1
FCF growth	255.65%
FCF growth (QoQ)	106.99%
FCF growth 3Y	13.29%
FCF growth 5Y	9.63%
Gross profit growth	22.92%
Gross profit growth (Q)	24.3%
Gross profit growth 3Y	15.64%
Gross profit growth 5Y	16.8%
Net income growth	38.35%
Net income growth (Q)	11.07%
Net income growth (QoQ)	-53.48%
Net income growth 3Y	15.82%
Net income growth quarters	3
Net income growth years	1
OCF growth	176.74%
OCF growth (Q)	2,329.41%
OCF growth (QoQ)	98.27%
OCF growth 10Y	4.91%
OCF growth 3Y	14.06%
OCF growth 5Y	10.28%
Operating income growth	30.32%
Operating income growth (Q)	23.65%
Operating income growth 3Y	22.48%
Operating income growth 5Y	11.75%
Revenue growth	5.09%
Revenue growth (Q)	5.07%
Revenue growth (QoQ)	8.17%
Revenue growth 10Y	8.68%
Revenue growth 3Y	9.36%
Revenue growth 5Y	10.25%
Revenue growth quarters	51
Revenue growth years	12

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-573.4M
Depreciation and amortization	$792M
EBIT	$3.4B
EBITDA	$4.2B
EPS	$10.11
Financing cash flow	$1.2B
Free cash flow	$3.1B
Free cash flow minus SBC	$2.9B
Gross profit	$9.9B
Income taxes	$729.1M
Investing cash flow	$-4.3B
Net borrowing	$2.4B
Net cash flow	$444.4M
Net income	$2B
Operating cash flow minus SBC	$3.5B
Operating income	$3.4B
Revenue	$250.8B
Stock-based compensation	$112.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.7
Book value per share	$12.05
Debt / EBITDA	2.44
Debt / equity	4.47
Debt / FCF	3.56
Goodwill	$12.4B
Interest coverage	8.78
Long-term assets	$21.6B
Long-term liabilities	$16.3B
Net cash (debt)	$-8.8B
Net cash / market cap	-18.81%
Net debt / EBITDA	2.1
Net debt / equity	3.6
Net debt / FCF	2.87
Piotroski F-Score	6
Property, plant and equipment	$2.1B
Shareholders' equity	$2.4B
Tangible book value	$-14.6B
Tangible book value per share	$-76.60
Total assets	$63.2B
Total cash	$2.1B
Total debt	$10.9B
Total liabilities	$60.7B
WACC	6.53%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	4.22
Current assets	$41.6B
Current liabilities	$44.5B
Current ratio	0.93
Inventory turnover	15.53
Net working capital	$-4.5B
Quick ratio	0.48
Working capital	$-2.9B
Working capital turnover	-55.7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.46%
Dividend growth	9.09%
Dividend growth (3Y)	7.35%
Dividend growth (5Y)	6.4%
Dividend growth years	7
Dividend payment date	2026-08-31
Dividend payment years	9
Dividend payout frequency	Quarterly
Dividend per share	$1.81
Dividend yield	0.74%
Ex-dividend date	2026-08-14
Last dividend	$0.60
Payout ratio	17.83%
Shareholder yield	1.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$305.37
1D price change	-0.48%
1M price change	6.7%
1M total return	6.7%
1W price change	-4.84%
1W total return	-4.84%
1Y price change	-2.76%
1Y return CAGR	-2.02%
1Y total return	-2.02%
20-day SMA	$327.73
200-day SMA	$317.43
3M price change	4.5%
3M total return	4.7%
3Y price change	74.03%
3Y return CAGR	21.29%
3Y total return	78.45%
50-day SMA	$323.09
50-day SMA vs 200-day SMA	50over200
52-week high	$381.28
52-week high date	2026-03-02
52-week low	$245.77
52-week low date	2026-05-06
5Y price change	170.45%
5Y return CAGR	23.24%
5Y total return	184.26%
6M price change	4.9%
6M total return	5.34%
All-time high	$381.28
All-time high date	2026-03-02
All-time low	$71.98
All-time low date	2018-12-24
Average true range (ATR)	$8.91
Average volume	296.4
Beta (5Y)	0.58
Change from 52-week high	-14.57%
Change from 52-week low	32.54%
Change from all-time high	-14.57%
Change from all-time low	352.53%
Change from open	0.39%
Day's gap	-0.87%
Dollar volume	$499,674
High price	$327.21
Low price	$321.16
Monthly RSI	57.1
Open price	$324.48
Position in 52-week range	75.59%
Previous close	$327.32
Price vs 150-day SMA	6.67%
Price vs 20-day SMA	-0.61%
Price vs 200-day SMA	2.62%
Price vs 50-day SMA	0.82%
Relative volume	5.68
RSI	48.48
Sharpe ratio	-0.01
Sharpe ratio (3Y)	0.75
Sharpe ratio (5Y)	0.81
Sortino ratio	0.16
Sortino ratio (3Y)	1.22
Sortino ratio (5Y)	1.35
Volume	1.5K
Weekly RSI	53.83
YTD price change	-4.29%
YTD total return	-3.72%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	180.3M
Shares change (QoQ)	-0.74%
Shares change (YoY)	-0.46%
Shares held by insiders	0.38%
Shares held by institutions	97.28%
Short ratio	3 days

Deeper analysis on LON/0HF3

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LON/0HF3 report

Is a complete LON/0HF3 research report available?

No complete published report is available for lon/0HF3 (LON/0HF3) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0HF3 (LON/0HF3)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0HF3

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0HF3 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0HF3

Frequently asked questions